Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.

Authors :: Lanzillo R
Moccia M
Carotenuto A
Vacchiano V
Satelliti B
Panetta V
Brescia Morra V
Source :: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2015 Aug; Vol. 21 (9), pp. 1215-6. Date of Electronic Publication: 2015 Feb 06.
Publication Year :: 2015

Subjects :: Cross-Over Studies
Humans
Immunologic Factors administration & dosage
Injections, Subcutaneous adverse effects
Interferon-beta administration & dosage
Pain Measurement
Skin Cream therapeutic use
Immunologic Factors adverse effects
Interferon-beta adverse effects
Multiple Sclerosis, Relapsing-Remitting drug therapy
Vitamin K administration & dosage

Full Text Access

Tools